1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Gene Editing Market, By Product
5.1 Introduction
5.2 Software & Systems
5.3 Services
5.4 Reagents & Consumables
6 Global Gene Editing Market, By Technology
6.1 Introduction
6.2 Transcription Activator-Like Effector Nuclease
6.3 Antisense
6.4 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
6.5 Zinc Finger Nuclease (ZFN)
6.6 Other Technologies
7 Global Gene Editing Market, By Application
7.1 Introduction
7.2 Genetic Engineering
7.3 Cell Line Engineering
7.4 Drug Discovery & Development
7.5 Other Applications
8 Global Gene Editing Market, By End User
8.1 Introduction
8.2 Academic and Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Other End Users
9 Global Gene Editing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Sangamo Therapeutics, Inc.
11.2 Beam Therapeutics
11.3 Integrated DNA Technologies, Inc.
11.4 Thermo Fisher Scientific
11.5 Horizon Discovery Ltd.
11.6 Precision Biosciences
11.7 CRISPR Therapeutics
11.8 GeneScript
11.9 Agilent Technologies
11.10 Intellia Therapeutics, Inc.
11.11 Caribou Biosciences, Inc.
11.12 Lonza
11.13 Perkinelmer
11.14 Editas Medicine
11.15 Tecan Life Sciences
11.16 Amsbio
11.17 Creative Biogene
List of Tables
Table 1 Global Gene Editing Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 4 Global Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 5 Global Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 6 Global Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 7 Global Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 8 Global Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 9 Global Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 10 Global Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 11 Global Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 12 Global Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 13 Global Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 14 Global Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 15 Global Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 16 Global Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 17 Global Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 18 Global Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 19 Global Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 20 Global Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 21 North America Gene Editing Market Outlook, By Country (2021-2030) ($MN)
Table 22 North America Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 23 North America Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 24 North America Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 25 North America Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 26 North America Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 27 North America Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 28 North America Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 29 North America Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 30 North America Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 31 North America Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 32 North America Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 33 North America Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 34 North America Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 35 North America Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 36 North America Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 37 North America Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 38 North America Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 39 North America Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 40 North America Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 41 Europe Gene Editing Market Outlook, By Country (2021-2030) ($MN)
Table 42 Europe Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 43 Europe Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 44 Europe Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 45 Europe Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 46 Europe Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 47 Europe Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 48 Europe Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 49 Europe Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 50 Europe Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 51 Europe Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 52 Europe Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 53 Europe Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 54 Europe Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 55 Europe Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 56 Europe Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 57 Europe Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 58 Europe Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 59 Europe Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 60 Europe Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 61 Asia Pacific Gene Editing Market Outlook, By Country (2021-2030) ($MN)
Table 62 Asia Pacific Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 63 Asia Pacific Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 64 Asia Pacific Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 65 Asia Pacific Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 66 Asia Pacific Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 67 Asia Pacific Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 68 Asia Pacific Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 69 Asia Pacific Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 70 Asia Pacific Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 71 Asia Pacific Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 72 Asia Pacific Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 73 Asia Pacific Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 74 Asia Pacific Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 75 Asia Pacific Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 76 Asia Pacific Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 77 Asia Pacific Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 78 Asia Pacific Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 79 Asia Pacific Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 80 Asia Pacific Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 81 South America Gene Editing Market Outlook, By Country (2021-2030) ($MN)
Table 82 South America Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 83 South America Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 84 South America Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 85 South America Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 86 South America Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 87 South America Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 88 South America Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 89 South America Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 90 South America Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 91 South America Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 92 South America Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 93 South America Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 94 South America Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 95 South America Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 96 South America Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 97 South America Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 98 South America Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 99 South America Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 100 South America Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 101 Middle East & Africa Gene Editing Market Outlook, By Country (2021-2030) ($MN)
Table 102 Middle East & Africa Gene Editing Market Outlook, By Product (2021-2030) ($MN)
Table 103 Middle East & Africa Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
Table 104 Middle East & Africa Gene Editing Market Outlook, By Services (2021-2030) ($MN)
Table 105 Middle East & Africa Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
Table 106 Middle East & Africa Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
Table 107 Middle East & Africa Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
Table 108 Middle East & Africa Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
Table 109 Middle East & Africa Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
Table 110 Middle East & Africa Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
Table 111 Middle East & Africa Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 112 Middle East & Africa Gene Editing Market Outlook, By Application (2021-2030) ($MN)
Table 113 Middle East & Africa Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
Table 114 Middle East & Africa Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
Table 115 Middle East & Africa Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
Table 116 Middle East & Africa Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
Table 117 Middle East & Africa Gene Editing Market Outlook, By End User (2021-2030) ($MN)
Table 118 Middle East & Africa Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
Table 119 Middle East & Africa Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 120 Middle East & Africa Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 遺伝子組み換え、または遺伝子編集は、生物の遺伝情報を直接的に変更する技術の総称です。この技術は、特定の遺伝子を追加、削除、あるいは置き換えることで、生物の性質や機能を変更することを目的としています。遺伝子組み換えは、医学、農業、産業など、さまざまな分野で活用されています。 遺伝子編集の主な種類には、クリスパー（CRISPR-Cas9）、タリ（TALEN）、ザイプ（ZFN）などがあります。特にCRISPRは、その簡便さと迅速さから広く利用されています。CRISPRは、特定のDNA配列をターゲットにして切断し、その後に望ましい遺伝子を挿入することが可能です。この技術は、生命科学の研究だけでなく、農業における新品種の開発や医療における治療法の開発にも利用されています。 遺伝子編集の用途は多岐にわたります。農業分野では、遺伝子組み換え作物が開発されることで、病害虫に強い品種や収量の向上が期待されています。また、環境に優しい農業を実現するため、化学肥料や農薬を減少させることも目指されています。一方、医療分野では、遺伝子編集技術を用いて遺伝子疾患やがんの治療法が研究されています。特に、遺伝子治療は、特定の遺伝子の異常を修正することによって疾患を治す可能性を秘めています。 関連技術としては、遺伝子の挿入・削除を行うためのベクター技術、バイオインフォマティクス、遺伝子発現解析などがあります。これらの技術は、遺伝子編集をより効果的に行い、目的の性質を持つ生物を作り出すためのものです。例えば、バイオインフォマティクスは、遺伝子の配列解析や変異の予測を行うことで、より精度の高い編集を実現します。 また、倫理的な観点からも遺伝子編集は注目されています。特に人間の遺伝子を編集することに対する懸念が高まっています。遺伝子編集が持つポテンシャルとは裏腹に、不適切な利用や意図しない影響が問題視されています。このため、多くの国や地域で法律やガイドラインが整備されつつあります。 遺伝子編集技術は、進化を続けており、今後の研究開発により新たな方法や応用が期待されています。一方で、社会的な合意や規制が必要であることも忘れてはいけません。技術の進歩を追いながら、その利用が人類にとって有益であるようにすることが求められます。 総じて、遺伝子組み換えは未来の農業や医療に大きな影響を与える技術です。持続可能な社会の実現に向けて、科学者たちはこの技術を駆使して新たな解決策を見出していくことでしょう。適切な倫理的、法的枠組みの中で、遺伝子編集の技術を発展させていくことが重要です。 |
